New combination of anti-viral drugs is very effective against Covid, know what else this research says
Sarah Cherry, a professor at the University of Pennsylvania in the US and lead researcher of the study, said identifying the anti-viral mixture is really important. Doing so can not only increase the potency of drugs against the corona virus but also reduce the risk of resistance.
Scientists have found in a new study on rats that a combination of the anti-viral drugs remdesivir or mollupiravir and the experimental drug brequinar inhibited the spread of the SARS-CoV-2 virus, which causes the disease of Covid-19 in lung cells. Is.
The study, published recently in the journal Nature, suggests that using a combination of drugs is more effective than using them separately.
Researchers said that there is no clinical trial at the moment, but the combination of drugs in the study opens up possibilities of effective treatment of Covid-19.
It is really important to identify the anti-viral mix
Sarah Cherry, a professor at the University of Pennsylvania in the US and lead researcher of the study, said, 'It is really important to identify the anti-viral mixture. Doing this not only increases the potency of drugs against the corona virus, but also reduces the risk of resistance.
Researchers tested 18,000 drugs
The researchers said that there is an urgent need to treat Covid because there is an increasing risk of new variants, which can also break the safety cycle of the vaccine. Scientists tested 18 thousand drugs using the SARS-CoV-2 virus to discover a new mixture.